JP5546087B2 - 皮膚疾患経口治療または予防剤 - Google Patents

皮膚疾患経口治療または予防剤 Download PDF

Info

Publication number
JP5546087B2
JP5546087B2 JP2005036235A JP2005036235A JP5546087B2 JP 5546087 B2 JP5546087 B2 JP 5546087B2 JP 2005036235 A JP2005036235 A JP 2005036235A JP 2005036235 A JP2005036235 A JP 2005036235A JP 5546087 B2 JP5546087 B2 JP 5546087B2
Authority
JP
Japan
Prior art keywords
dgla
intake
therapeutic
gla
prophylactic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2005036235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006219454A (ja
JP2006219454A5 (https=
Inventor
法史 立石
洋 河島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Priority to JP2005036235A priority Critical patent/JP5546087B2/ja
Priority to US11/884,199 priority patent/US9006287B2/en
Priority to EP19183855.6A priority patent/EP3581178B1/en
Priority to EP06713928.7A priority patent/EP1852114B1/en
Priority to PCT/JP2006/302787 priority patent/WO2006085687A1/ja
Priority to CA2599112A priority patent/CA2599112C/en
Priority to CN 200610003112 priority patent/CN101019853B/zh
Priority to CN2012100164426A priority patent/CN102600174A/zh
Publication of JP2006219454A publication Critical patent/JP2006219454A/ja
Publication of JP2006219454A5 publication Critical patent/JP2006219454A5/ja
Application granted granted Critical
Publication of JP5546087B2 publication Critical patent/JP5546087B2/ja
Priority to US14/644,231 priority patent/US9943495B2/en
Priority to US15/911,806 priority patent/US10342773B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2005036235A 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤 Expired - Fee Related JP5546087B2 (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2005036235A JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤
EP19183855.6A EP3581178B1 (en) 2005-02-14 2006-02-10 Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient
EP06713928.7A EP1852114B1 (en) 2005-02-14 2006-02-10 Composition containing dihomo-y-linolenic acid (dgla) as active ingredient
PCT/JP2006/302787 WO2006085687A1 (ja) 2005-02-14 2006-02-10 ジホモ−γ−リノレン酸（ＤＧＬＡ）を有効成分として含んで成る組成物
CA2599112A CA2599112C (en) 2005-02-14 2006-02-10 Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
US11/884,199 US9006287B2 (en) 2005-02-14 2006-02-10 Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient
CN 200610003112 CN101019853B (zh) 2005-02-14 2006-02-14 含有有效成分二均-γ-亚麻酸(DGLA)的组成物
CN2012100164426A CN102600174A (zh) 2005-02-14 2006-02-14 含有有效成分二均-γ-亚麻酸(DGLA)的组成物
US14/644,231 US9943495B2 (en) 2005-02-14 2015-03-11 Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient
US15/911,806 US10342773B2 (en) 2005-02-14 2018-03-05 Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005036235A JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012013311A Division JP2012082226A (ja) 2012-01-25 2012-01-25 皮膚疾患経口治療または予防剤

Publications (3)

Publication Number Publication Date
JP2006219454A JP2006219454A (ja) 2006-08-24
JP2006219454A5 JP2006219454A5 (https=) 2008-03-27
JP5546087B2 true JP5546087B2 (ja) 2014-07-09

Family

ID=36981996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005036235A Expired - Fee Related JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤

Country Status (2)

Country Link
JP (1) JP5546087B2 (https=)
CN (1) CN101019853B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006306812A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 好酸球浸潤抑制剤
JP2006306813A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 肥満細胞増殖抑制剤
WO2006085687A1 (ja) 2005-02-14 2006-08-17 Suntory Limited ジホモ−γ−リノレン酸（ＤＧＬＡ）を有効成分として含んで成る組成物
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
WO2012153832A1 (ja) 2011-05-12 2012-11-15 日本水産株式会社 炎症性疾患用皮膚外用組成物
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US9855236B2 (en) 2011-10-19 2018-01-02 Ds Biopharma Limited Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof
SG11201401629XA (en) * 2011-10-19 2014-05-29 Dignity Sciences Ltd Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
PL3077489T3 (pl) 2013-12-04 2021-11-08 Nippon Suisan Kaisha, Ltd. Olej drobnoustrojowy zawierający kwas dihomo-gamma-linolenowy i biomasa drobnoustrojowa zawierająca kwas dihomo-gamma-linolenowy
ES2784240T3 (es) 2014-06-04 2020-09-23 Ds Biopharma Ltd Composiciones farmacéuticas que comprenden DGLA y uso de las mismas
EP3399971A1 (en) * 2016-01-07 2018-11-14 DS Biopharma Limited Pharmaceutical compositions comprising dgla and use of same
BR112018073060A2 (pt) * 2016-06-01 2019-04-09 Nestec S.A. composição para uso na profilaxia de doença alérgica
EP3624787A1 (en) * 2017-05-19 2020-03-25 DS Biopharma Limited Pharmaceutical compositions comprising dgla and use of same
AU2019417798B2 (en) * 2018-12-28 2025-08-14 Nippon Suisan Kaisha, Ltd. Dihomo-γ-linolenic acid-containing microbial oil with reduced arachidonic acid content
CN114585355A (zh) * 2019-10-01 2022-06-03 三得利控股株式会社 借由水通道蛋白3的表达调节的肠功能改善用组合物及其应用
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases
US20240398747A1 (en) * 2021-10-13 2024-12-05 Kao Corporation Anti-allergic agent
EP4417200A4 (en) * 2021-10-13 2025-10-15 Kao Corp AGENT FOR THE PREVENTION, TREATMENT OR ALLEVIATION OF INFLAMMATORY SKIN DISEASE
WO2023181755A1 (ja) * 2022-03-22 2023-09-28 東洋紡株式会社 皮膚機能関連因子に関する遺伝子の発現調節剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB8806737D0 (en) * 1988-03-22 1988-04-20 Efamol Holdings Therapeutic composition & method
JP2002047176A (ja) * 2000-08-04 2002-02-12 Idemitsu Technofine Co Ltd ＩｇＥ産生抑制剤

Also Published As

Publication number Publication date
JP2006219454A (ja) 2006-08-24
CN101019853A (zh) 2007-08-22
CN101019853B (zh) 2013-05-15

Similar Documents

Publication Publication Date Title
US10342773B2 (en) Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient
JP5546087B2 (ja) 皮膚疾患経口治療または予防剤
JP7007010B2 (ja) 脂質含有組成物およびその使用方法
Kroes et al. A review of the safety of DHA45-oil
EP2682116B1 (en) Metabolic syndrome ameliorating agent
WO2008059965A1 (en) Agent for alleviating or preventing stress symptoms and agent for improving mental conditions
Bhat Functional lipids as nutraceuticals: a review
JP6203320B2 (ja) 皮膚疾患経口治療または予防剤
JP2010105946A (ja) 筋タンパク質増強剤及びこれを含む医薬品または食品
JP2012082226A (ja) 皮膚疾患経口治療または予防剤
JP2013063937A (ja) Ｇｉｐ上昇抑制剤
JP6462790B2 (ja) 皮膚疾患経口治療または予防剤
JP2006306812A (ja) 好酸球浸潤抑制剤
JP6214474B2 (ja) 皮膚疾患経口治療または予防剤
JP2006306813A (ja) 肥満細胞増殖抑制剤
JP5759663B2 (ja) 皮膚バリア機能改善剤等
JP5479696B2 (ja) 生体内のプラスマローゲン増加剤
JP2024051305A (ja) 糖質燃焼促進剤
Nath et al. Role of Omega-3s in Functional Foods
EP3632422B1 (en) Composition comprising monounsaturated fatty acids having 20 or more carbon atoms for use in improving vascular endothelial function
Hernandez et al. Applications of omega-3 fats in foods
JP2019019069A (ja) 体脂肪低減剤
CN107970232A (zh) 含n-3系不饱和脂肪酸的组合物、及n-3系不饱和脂肪酸在该组合物的制造中的应用
JP2018168139A (ja) ｎ−３系不飽和脂肪酸を含む中性脂肪値の低減または上昇抑制用の組成物、並びに該組成物の製造におけるｎ−３系不飽和脂肪酸の使用
WO2008153220A1 (ja) 血管疾患の予防又は治療剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080213

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080213

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20090424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110524

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110722

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111025

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120125

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20120315

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20120427

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140310

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140513

R150 Certificate of patent or registration of utility model

Ref document number: 5546087

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees